XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Millions
Total
Common Stock
Capital in Excess of Par Value
Retained Earnings
Accumulated Other Comprehensive (Loss) Income
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2023   306,058,815        
Beginning balance at Dec. 31, 2023 $ 2,782 $ 3 $ 2,062 $ 1,029 $ (313) $ 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net Income 165     165    
Other Comprehensive Income (Loss), Net of Tax:            
Derivative Instruments (1)       (1)  
Currency Translation Adjustment (57)       (57)  
Dividends Declared (31)     (31)    
Issuance of Shares for Stock-Based Awards (in shares)   1,234,251        
Ending balance (in shares) at Mar. 31, 2024   307,293,066        
Ending balance at Mar. 31, 2024 $ 2,858 $ 3 2,062 1,163 (371) 1
Beginning balance (in shares) at Dec. 31, 2024 300,163,372 300,163,372        
Beginning balance at Dec. 31, 2024 $ 3,013 $ 3 2,054 1,410 (455) 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net Income 127     127    
Other Comprehensive Income (Loss), Net of Tax:            
Derivative Instruments 5       5  
Currency Translation Adjustment 77       77  
Dividends Declared (33)     (33)    
Recognition of Stock-Based Compensation, Net $ (31)   (31)      
Issuance of Shares for Stock-Based Awards (in shares)   1,590,909        
Ending balance (in shares) at Mar. 31, 2025 301,754,281 301,754,281        
Ending balance at Mar. 31, 2025 $ 3,158 $ 3 $ 2,023 $ 1,504 $ (373) $ 1